Viewing Study NCT01670812


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2026-01-16 @ 8:48 PM
Study NCT ID: NCT01670812
Status: UNKNOWN
Last Update Posted: 2012-08-22
First Post: 2012-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic lymphocytic leukemia View
None ultra-high risk View
None fresh frozen plasma View
None methylprednisolone View
None rituximab View